Non-insulin dependent diabetes needs more attentionBMJ 1996; 313 doi: https://doi.org/10.1136/bmj.313.7056.510a (Published 31 August 1996) Cite this as: BMJ 1996;313:510
The financial, medical, and personal impact of non-insulin dependent diabetes has been greatly underestimated, says a London based health policy group, the King's Fund.
The fund estimates that the cost of treating the complications, which affect 85% of all people with diabetes and over a million people in Britain, is at least double previous estimates and may be as high as £2bn ($3.5bn) a year. Its report found that by 2011 expenditure on diabetes could total 10% of NHS revenue.
The World Health Organisation has already warned of a worldwide epidemic of non-insulin dependent diabetes, while in Britain longevity, together with obesity and physical inactivity, is likely …